Collaborative Projects. Collaboration between healthcare and the pharmaceutical industry can have various features and different aims and purposes. In respect of clinical trials, for example, separate agreements have been concluded, and the conditions for those trials are regulated separately. Collaborative projects between pharmaceutical companies and healthcare shall be understood in these rules as cooperation in projects with the aim of improving support to patients, enhancing quality of care, or otherwise contributing to increased patient benefit. For such projects, the following applies: Proposals for collaborative projects shall be sent to the operations manager, who shall subsequently inform any relevant organizational levels. An agreement regarding a collaborative project may not constitute an assignment to an individual. The agreement shall be concluded by the pharmaceutical company and a unit within healthcare. The agreement may not imply exclusivity for the pharmaceutical company to provide certain kinds of services to one or more healthcare providers. Both the healthcare and the company shall contribute to the collaborative project with resources such as funds, materials and working time. A project plan shall exist, which, for example, shall regulate how the project should be evaluated. The collaborative project shall be reported to the public and be available in LIF's cooperation database.
Appears in 2 contracts
Sources: Cooperation Agreement, Cooperation Agreement